Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
1.40%
Price
19:24
€169.34
Summary
This prediction is currently active. With a performance of 1.40%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 1.101% | 1.101% |
| iShares Core DAX® | -2.195% | 0.670% |
| iShares Nasdaq 100 | -2.629% | 2.992% |
| iShares Nikkei 225® | -2.021% | 3.141% |
| iShares S&P 500 | -1.670% | 2.405% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat